Your SlideShare is downloading. ×
Autocoids
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Autocoids

1,245

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,245
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
76
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. INTRODUCTION Naturally occuring substances – termed as local harmones which originate from diffuse tissues & produce intense pharmacological action near their site of formation & release. Auto’s=Self ; akos= remedy/ medicinal agent.
  • 2. CLASSIFICATION Based on chemical nature; 1.BIOGENIC / ENDOGENOUS AMINES: Histamine, 5-HT. 2.POLYPEPTIDES:Bradykinin, sub-p. 3.LIPID SOLUBLE ORGANIC ACIDS/ PHOSPHO LIPID DERIVATIVES: (A).EICOSINOIDS: PG’S, PC’S, LT’S, TX’S. (B).PAF.
  • 3. HISTAMINE Tissue amine. Histos- Tissue. DISTRIBUTION: Widely distributed in almost all mammal tissues & in venom of bees & wasps. SYNTHESIS: In mammals formed by Decarboxylation of Histidine in prescence of Histidine decarboxylase. STORAGE: Present in platelets, leucocytes, basophills & mastcells. Mainly in mastcells & basophills due to presence of his.decarboxylase, specialised storage granules.
  • 4. MECHANISM OF ACTION Acts through 4 receptors viz : H1, H2, H3, H4 – all belonging to family GPCR. Activation of H1 receptors : Activation of H2 receptors:
  • 5. PHARMACOLOGICAL ACTIONS CVS: (A). BLOOD VESSELS: In herbivores – Sys & Pul vasoconstriction. In humans Pul.vasodilation. Acts by 3 ways: (a).Activation of H1 receptors on the endothelial cells cause rapid- short lived vasodilation. (b).Activation of H2 receptors in the vascular smooth muscle causes slower but prolonged vasodilation. (c).Relaxation of smooth muscle of capillaries & venules leading to their dilation and fall in BP.
  • 6. PHARMACOLOGICAL ACTIONS (B).BP: Therapeutic doses induces hypotension, short lived. Large doses –prolonged hypotension. Hypotension left untreated may cause irreversible shock & death. Histamine induced hypotension is partially reversed by anti-histaminics & completely reversed by adrenaline.
  • 7. PHARMACOLOGICAL ACTIONS TRIPLE RESPONSE; When given (20mcg) ID develops a triple response : (a).FLUSH(RED REACTION): Red line r spot develop with in 10sec, due to local dilation of capillaries & venules. (b).WHEAL: Local swelling due to edema, mottled reddening around injury. Lasts about 1 1/2min. Due to increased permeability of capillaries 7 post capillary venules with consequent xtravasation of fluid.
  • 8. PHARMACOLOGICAL ACTIONS (c).FLARE: Redness with irregular margins spreads out from injury. Triple response is part of normal reaction to injury. Its prevention is used to evaluate anti-histaminic activity of a new drug. (C).HEART:Increases sinus rate (+ve chronotropic action) Increases the amplitude of ventricular contraction (+inotropic effect) Decreases AV conduction time & increases coronary blood flow, high conc. induce ven.fibrillation.
  • 9. PHARMACOLOGICAL ACTIONS (D)SMOOTH MUSCLE: Stimulates smooth muscles of various tissues by direct action(H1). Bronchial & Uterine smooth muscle – highly sensitive. GIT & Ureteral smooth muscle – respond moderately. Thru H1 receptor – gall bladder contraction , H2 receptor – gall bladder relaxation. ‘H’ –induced bronchospasm – antagonised by adrenaline, isoprenaline & aminophylline but not by anti-histaminics r atropine.
  • 10. PHARMACOLOGICAL ACTIONS ENDOCRINE GLANDS: Important physiological mediator of gastric acid secretion. CNS: Doesn’t cross BBB, ‘H’ constituted in 2types of cells – Histaminergic neurones & Mast cells. Considered as ‘Waking amine’- increase in sensitivity of large cerebral areas to excitatory inputs. IMMUNOMODULATION: Increases Humoral & Cellular immunity by various receptors , H1- cellular immunity , H2- Humoral immunity.
  • 11. A,D,M,E: Stable compound & absorbed from all sites . Rapidly under go first pass metabolism in liver. Metabolism varies acc.to: animal spcs, sex , organ studied. Chemically it is B-Imidazolyl etylamine. End products of metabolism include N-Methyl imidazole aectic acid, N-acetyl histamine.
  • 12. ADR Due to pharmacological actions: hypotension, visual disturbances, dyspnea, diarrhoea. Man, Gunea pig- extremely sensitive. Rats & Mice – highly resistant. Large dose causes – severe nausea, gripping, headache & sweating. USES:Study of gastric acid secretion.
  • 13. ANTI-HISTAMINICS Certain phenolic ether – anti-histaminic properties. CLASSIFICATION: By two ways Clinically & Chemically. (A).CLINICAL CLASSIFICATION: 1.POTENT & SEDATIVE: Diphenhydramine, Promethazine. 2.POTENT & LESS SEDATIVE: Cyclizine, Meclizine. 3.LESS POTENT & LESS SEDATIVE: Antazoline, Cinnarizine. 4.NON SEDATIVE: Loratidine, Cetirizine.
  • 14. CHEMICAL CLASSIFICATION General formula: Based on configuration of ‘X’ classified as : 1. ETHANOLAMINES(X=‘O’): Diphenhydramine, Doxylamine. 2.ETHYLENE DIAMINES(X=‘N’): Mepiramine, Antazoline. (show negligible anti-cholinergic & anti-emetic efcts) 3.ALKYL AMINES (X=‘C’): Chloropheneramine, Triprolidine. 4.PIPERAZINES: (X=‘C’ in conjunction with piperazine ring): Cinnarizine, Cetirizine.
  • 15. CHEMICAL CLASSIFICATION 5.PHENO THIAZINES (X=‘N’ as apart of phenothiazine nucleus): Promethazine, Trimeprazine, show potent anti-emetic effect. 6.PIPERIDINES: Loratadine, Fexofenadine. 7.DIBENZOXYPINES: Doxepine (Tricyclic anti depressant) shows potent anti-histaminic properties.
  • 16. ‘H’- ANTAGONISTIC ACTIONS 1.ANTI-HISTAMINIC ACTIONS: Competatively block ‘H’ at various sites. Antgonize stimulant action of ‘H’ on: Smooth muscle of GIT, bronchi, uterus & bld.ves. Reduce ‘H’ induced triple response. Anti-allergic & anti-inflammatory actions involve: (a). Inhibition of release of mediators from mastcells, basophills. (b).Down regulation of H1-receptors. Don’t antgonize CVS actions of ‘H’.
  • 17. ANTAGONISTIC ACTIONS OTHER ACTIONS: Related to their blocking of 5-HT & A1-Adreno receptors. 1.SEDATION & HYPNOSIS: CNS depression – common side effect. Induce varying degrees of sedation, drowsiness & sleep. 2.CNS STIMULATION: Stimulation is less , conventional doses of Promethazine cause restlessness, tremors & insomnia.
  • 18. ANTAGONISTIC ACTIONS 3. ON ANS: First gen. anti-histaminics show muscarinic blocking activity, second gen. anti- histaminics doesn’t show these actions. 4.ANTI-EMETIC & ANTI-MOTION SICKNESS: Diphenhydramine & Promethazine block histaminergic signals from the vestibular nucleus to vomiting center. 5.ANTI-PARKINSONIAN EFFECTS: Central anti- muscarinic actions useful in treating parkinsonism.
  • 19. ANTAGONISTIC ACTIONS 6.CVS: Rapid IV administration of Diphenhydramine, Antazoline may produce dose related prolongation of QT interval due to membrane stabilising effect. 7.LOCAL ANAESTHESIA: Promethazine, Diphenhydramine exhibit local anaesthetic activity. A,D,M,E: Well absorbed orally & parenterally. Anti-histaminic effect starts with in 15-30 min, peaks by 1hr & lasts for 3-6hrs. Meclizine- action persists for 12-24hrs.
  • 20. ANTAGONISTIC ACTIONS A,DM,E: First gen compounds metabolised by CYP3A4 in liver. H1-antagonists induce hepatic microsomal enzymes, facilitating their own metabolism. ADR: Mild, 1.CNS: Sedation & Hypnosis, Fatigue. In children less than 2yrs- Promethazine cause Apnoea. ANTI-MUSCARINIC EFFECTS: Dry mouth, blurred vision, bladder disturbances & rarely impotence.
  • 21. ADR: GIT: Nausea, vomiting, epi-gastric distress. MISC: May produce allergic manifestations despite of their anti-allergic & anti-inflammatory properties.
  • 22. THERAPEUTIC USESUsed in treatment of : 1.Allergic disorders,2.Reagenic allergy,3. Allergic conjunctivitis ,4. Mastocytosis,5.Other uses (a).As hypnotics, (b).As anti-emetics, (c).In parkinsonism, (d).In motion sickness & vertigo, (e).Anti-tussives, (f).Local anaesthetics.

×